Estrogen (ER) and Progesterone Receptors (PR) and their ligands, known factors involved in breast cancer initiation and progression, are able to determine a dynamic bio-molecular context correlated with breast tumor heterogeneity [1, 2]. Here, PGR is linked to breast neoplasm.